BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces. 2007;58:157-164. [PMID: 17446050 DOI: 10.1016/j.colsurfb.2007.03.002] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Ganesan P, Narayanasamy D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustainable Chemistry and Pharmacy 2017;6:37-56. [DOI: 10.1016/j.scp.2017.07.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 44] [Article Influence: 24.2] [Reference Citation Analysis]
2 Bandiwadekar A, Jose J, Khayatkashani M, Habtemariam S, Khayat Kashani HR, Nabavi SM. Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases. J Mol Neurosci 2021. [PMID: 34697770 DOI: 10.1007/s12031-021-01922-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shangguan M, Qi J, Lu Y, Wu W. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. International Journal of Pharmaceutics 2015;489:195-202. [DOI: 10.1016/j.ijpharm.2015.05.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
4 Jianghong L, Tingting M, Yingping Z, Tong Y, Lanxia Z, Jingwen L, Wentao Z, Pengbo C, Hong Y, Fuqiang H. Aptamer and Peptide-Modified Lipid-Based Drug Delivery Systems in Application of Combined Sequential Therapy of Hepatocellular Carcinoma. ACS Biomater Sci Eng 2021;7:2558-68. [PMID: 34047187 DOI: 10.1021/acsbiomaterials.1c00357] [Reference Citation Analysis]
5 da Silva Santos V, Badan Ribeiro AP, Andrade Santana MH. Solid lipid nanoparticles as carriers for lipophilic compounds for applications in foods. Food Res Int 2019;122:610-26. [PMID: 31229120 DOI: 10.1016/j.foodres.2019.01.032] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
6 Zhang J, Lv Y, Wang B, Zhao S, Tan M, Lv G, Ma X. Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions. Mol Pharm 2015;12:695-705. [PMID: 25608210 DOI: 10.1021/mp500475y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
7 McClements DJ, Rao J. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr 2011;51:285-330. [PMID: 21432697 DOI: 10.1080/10408398.2011.559558] [Cited by in Crossref: 820] [Cited by in F6Publishing: 596] [Article Influence: 74.5] [Reference Citation Analysis]
8 Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids and Surfaces B: Biointerfaces 2012;97:109-16. [DOI: 10.1016/j.colsurfb.2012.04.027] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 7.5] [Reference Citation Analysis]
9 Miao J, Du Y, Yuan H, Zhang X, Hu F. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids and Surfaces B: Biointerfaces 2013;110:74-80. [DOI: 10.1016/j.colsurfb.2013.03.037] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
10 Nirbhavane P, Vemuri N, Kumar N, Khuller GK. Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin. AAPS PharmSciTech 2017;18:829-37. [PMID: 27350276 DOI: 10.1208/s12249-016-0559-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
11 Meng K, Chen D, Yang F, Zhang A, Tao Y, Qu W, Pan Y, Hao H, Xie S. Intracellular delivery, accumulation, and discrepancy in antibacterial activity of four enrofloxacin-loaded fatty acid solid lipid nanoparticles. Colloids Surf B Biointerfaces 2020;194:111196. [PMID: 32599504 DOI: 10.1016/j.colsurfb.2020.111196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Das S, Ng WK, Kanaujia P, Kim S, Tan RB. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables. Colloids and Surfaces B: Biointerfaces 2011;88:483-9. [DOI: 10.1016/j.colsurfb.2011.07.036] [Cited by in Crossref: 145] [Cited by in F6Publishing: 140] [Article Influence: 13.2] [Reference Citation Analysis]
13 Wang W, Shao A, Feng S, Ding M, Luo G. Physicochemical characterization and gastrointestinal adhesion of S-layer proteins-coating liposomes. International Journal of Pharmaceutics 2017;529:227-37. [DOI: 10.1016/j.ijpharm.2017.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
14 Ali H, Singh SK. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine. Therapeutic Delivery 2016;7:691-709. [DOI: 10.4155/tde-2016-0038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
15 Wang C, Chen S, Bao L, Liu X, Hu F, Yuan H. Size-Controlled Preparation and Behavior Study of Phospholipid-Calcium Carbonate Hybrid Nanoparticles. Int J Nanomedicine 2020;15:4049-62. [PMID: 32606663 DOI: 10.2147/IJN.S237156] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 7.5] [Reference Citation Analysis]
16 Sun C, Wang J, Liu J, Qiu L, Zhang W, Zhang L. Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics. AAPS PharmSciTech 2013;14:332-8. [PMID: 23319300 DOI: 10.1208/s12249-013-9924-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
17 Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release. 2009;133:238-244. [PMID: 18951932 DOI: 10.1016/j.jconrel.2008.10.002] [Cited by in Crossref: 399] [Cited by in F6Publishing: 352] [Article Influence: 28.5] [Reference Citation Analysis]
18 Dudhipala N, Ettireddy S, Youssef AAA, Puchchakayala G. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization. Molecules 2021;26:7538. [PMID: 34946619 DOI: 10.3390/molecules26247538] [Reference Citation Analysis]
19 Liu C, Wu C, Fang J. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Development and Industrial Pharmacy 2010;36:751-61. [DOI: 10.3109/03639040903460453] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
20 Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62-76. [PMID: 21174180 DOI: 10.1208/s12249-010-9563-0] [Cited by in Crossref: 390] [Cited by in F6Publishing: 314] [Article Influence: 32.5] [Reference Citation Analysis]
21 Zariwala M, Elsaid N, Jackson TL, Corral López F, Farnaud S, Somavarapu S, Renshaw D. A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles. International Journal of Pharmaceutics 2013;456:400-7. [DOI: 10.1016/j.ijpharm.2013.08.070] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
22 Mumuni M, Attama AA, Kunle OO. Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium. Drug Deliv 2016;23:917-25. [PMID: 24959939 DOI: 10.3109/10717544.2014.923062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170-184. [PMID: 18992314 DOI: 10.1016/j.ijpharm.2008.10.003] [Cited by in Crossref: 777] [Cited by in F6Publishing: 646] [Article Influence: 55.5] [Reference Citation Analysis]
24 Souto EB, Doktorovová S. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol 2009;464:105-29. [PMID: 19903552 DOI: 10.1016/S0076-6879(09)64006-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
25 Wang G, Wang J, Wu W, Tony To SS, Zhao H, Wang J. Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs. Expert Opin Drug Deliv 2015;12:1475-99. [PMID: 25843160 DOI: 10.1517/17425247.2015.1021681] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
26 Poovi G, Vijayakumar TM, Damodharan N. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review of the Effect of Physicochemical Formulation Factors in the Optimization Process, Different Preparation Technique, Characterization, and Toxicity. CNANO 2019;>15:436-53. [DOI: 10.2174/1573413714666180809120435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Muntoni E, Marini E, Ahmadi N, Milla P, Ghè C, Bargoni A, Capucchio MT, Biasibetti E, Battaglia L. Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies. Acta Diabetol 2019;56:1283-92. [PMID: 31407113 DOI: 10.1007/s00592-019-01403-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ezhilarasi PN, Muthukumar SP, Anandharamakrishnan C. Solid lipid nanoparticle enhances bioavailability of hydroxycitric acid compared to a microparticle delivery system. RSC Adv 2016;6:53784-93. [DOI: 10.1039/c6ra04312g] [Cited by in Crossref: 17] [Article Influence: 2.8] [Reference Citation Analysis]
29 Wang T, Luo Y. Biological fate of ingested lipid-based nanoparticles: current understanding and future directions. Nanoscale 2019;11:11048-63. [DOI: 10.1039/c9nr03025e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 6.7] [Reference Citation Analysis]
30 Mcclements DJ, Xiao H. Potential biological fate of ingested nanoemulsions: influence of particle characteristics. Food Funct 2012;3:202-20. [DOI: 10.1039/c1fo10193e] [Cited by in Crossref: 210] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
31 Balaz S. Modeling kinetics of subcellular disposition of chemicals. Chem Rev 2009;109:1793-899. [PMID: 19265398 DOI: 10.1021/cr030440j] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
32 Singh I, Swami R, Jeengar MK, Khan W, Sistla R. p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain. Chem Phys Lipids 2015;188:1-9. [PMID: 25819559 DOI: 10.1016/j.chemphyslip.2015.03.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
33 Xu Y, Wang Y, Li XM, Huang Q, Chen W, Liu R, Chen B, Wei P. Study on the release of fenofibrate nanosuspension in vitro and its correlation with in situ intestinal and in vivo absorption kinetics in rats. Drug Development and Industrial Pharmacy 2013;40:972-9. [DOI: 10.3109/03639045.2013.794828] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
34 Li W, Su C, Chen Y, Chen S. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs. Acta Biomaterialia 2015;15:191-9. [DOI: 10.1016/j.actbio.2014.12.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
35 Varshosaz J, Tabbakhian M, Mohammadi MY. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J Liposome Res 2010;20:286-96. [PMID: 19958118 DOI: 10.3109/08982100903443065] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
36 Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MH, Silva AM, Souto EB. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. J Drug Deliv 2012;2012:750891. [PMID: 22175030 DOI: 10.1155/2012/750891] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 10.9] [Reference Citation Analysis]
37 Durán-lobato M, Martín-banderas L, Lopes R, Gonçalves LMD, Fernández-arévalo M, Almeida AJ. Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility. Drug Development and Industrial Pharmacy 2016;42:190-8. [DOI: 10.3109/03639045.2015.1038274] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
38 Luo Y, Gao C, Chen W, Zhou K, Xu M. Molecular Magnetic Resonance Imaging with Contrast Agents for Assessment of Inflammatory Bowel Disease: A Systematic Review. Contrast Media Mol Imaging 2020;2020:4764985. [PMID: 32454803 DOI: 10.1155/2020/4764985] [Reference Citation Analysis]
39 Ahmed MM, Fatima F, Anwer MK, Aldawsari MF, Alsaidan YSM, Alfaiz SA, Haque A, Az A, Alhazzani K. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines. Chem Phys Lipids 2020;233:105003. [PMID: 33096096 DOI: 10.1016/j.chemphyslip.2020.105003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Shi H, Huang S, He J, Han L, Zhang W, Zhong Q. 1-Laurin-3-Palmitin as a Novel Matrix of Solid Lipid Particles: Higher Loading Capacity of Thymol and Better Stability of Dispersions Than Those of Glyceryl Monostearate and Glyceryl Tripalmitate. Nanomaterials (Basel) 2019;9:E489. [PMID: 30934814 DOI: 10.3390/nano9040489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Patel SG, Patel MD, Patel AJ, Chougule MB, Choudhury H. Solid Lipid Nanoparticles for Targeted Brain Drug Delivery. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. Elsevier; 2018. pp. 191-244. [DOI: 10.1016/b978-0-12-812218-1.00008-7] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Fang G, Tang B, Chao Y, Zhang Y, Xu H, Tang X. Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies. RSC Adv 2015;5:96437-47. [DOI: 10.1039/c5ra14588k] [Cited by in Crossref: 28] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ige PP, Baria RK, Gattani SG. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Colloids Surf B Biointerfaces 2013;108:366-73. [PMID: 23602990 DOI: 10.1016/j.colsurfb.2013.02.043] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 9.8] [Reference Citation Analysis]
44 Mcclements DJ. Encapsulation, protection, and release of hydrophilic active components: Potential and limitations of colloidal delivery systems. Advances in Colloid and Interface Science 2015;219:27-53. [DOI: 10.1016/j.cis.2015.02.002] [Cited by in Crossref: 238] [Cited by in F6Publishing: 190] [Article Influence: 34.0] [Reference Citation Analysis]
45 Hu K, Cao S, Hu F, Feng J. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine 2012;7:3537-45. [PMID: 22848177 DOI: 10.2147/IJN.S32880] [Cited by in Crossref: 61] [Cited by in F6Publishing: 24] [Article Influence: 6.1] [Reference Citation Analysis]
46 Lu YM, Huang JY, Wang H, Lou XF, Liao MH, Hong LJ, Tao RR, Ahmed MM, Shan CL, Wang XL, Fukunaga K, Du YZ, Han F. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials. 2014;35:530-537. [PMID: 24120040 DOI: 10.1016/j.biomaterials.2013.09.093] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
47 Liu X, Liu H, Wang SL, Liu JW. Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy. J Zhejiang Univ Sci B 2020;21:571-80. [PMID: 32633111 DOI: 10.1631/jzus.B1900624] [Reference Citation Analysis]
48 Yu M, Yang Y, Zhu C, Guo S, Gan Y. Advances in the transepithelial transport of nanoparticles. Drug Discov Today 2016;21:1155-61. [PMID: 27196527 DOI: 10.1016/j.drudis.2016.05.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
49 Wang J, Tao S, Jin X, Song Y, Zhou W, Lou H, Zhao R, Wang C, Hu F, Yuan H. Calcium Supplement by Tetracycline guided amorphous Calcium Carbonate potentiates Osteoblast promotion for Synergetic Osteoporosis Therapy. Theranostics 2020;10:8591-605. [PMID: 32754265 DOI: 10.7150/thno.45142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Liu C, Liu D, Bai F, Zhang J, Zhang N. In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery. Drug Deliv 2010;17:352-63. [PMID: 20387993 DOI: 10.3109/10717541003762839] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
51 Sun J, Zheng W, Zhang H, Wu T, Yuan H, Yang X, Zhang S. Development of nanoparticle-based magnetic resonance colonography. Magn Reson Med 2011;65:673-9. [PMID: 21337401 DOI: 10.1002/mrm.22654] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
52 Ramachandran S, Thangarajan S. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats. Chem Biol Interact 2016;256:25-36. [PMID: 27206696 DOI: 10.1016/j.cbi.2016.05.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
53 Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 2012;41:2260-8. [PMID: 23007664 DOI: 10.3892/ijo.2012.1636] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
54 Wu T, Zheng WL, Zhang SZ, Sun JH, Yuan H. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice. World J Gastroenterol 2011; 17(31): 3614-3622 [PMID: 21987608 DOI: 10.3748/wjg.v17.i31.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
55 Wan F, You J, Sun Y, Zhang X, Cui F, Du Y, Yuan H, Hu F. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): Preparation and evaluation in vitro. International Journal of Pharmaceutics 2008;359:104-10. [DOI: 10.1016/j.ijpharm.2008.03.030] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
56 Li M, Zahi MR, Yuan Q, Tian F, Liang H. Preparation and stability of astaxanthin solid lipid nanoparticles based on stearic acid: Astaxanthin solid lipid nanoparticles. Eur J Lipid Sci Technol 2016;118:592-602. [DOI: 10.1002/ejlt.201400650] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
57 Mcclements DJ. Crystals and crystallization in oil-in-water emulsions: Implications for emulsion-based delivery systems. Advances in Colloid and Interface Science 2012;174:1-30. [DOI: 10.1016/j.cis.2012.03.002] [Cited by in Crossref: 181] [Cited by in F6Publishing: 139] [Article Influence: 18.1] [Reference Citation Analysis]
58 Gaur PK. Nanosuspension of flavonoid-rich fraction from Psidium guajava Linn for improved type 2-diabetes potential. Journal of Drug Delivery Science and Technology 2021;62:102358. [DOI: 10.1016/j.jddst.2021.102358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Amekyeh H, Billa N, Yuen KH, Lim SC. Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats. AAPS PharmSciTech 2016;17:1060-6. [PMID: 26511938 DOI: 10.1208/s12249-015-0438-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
60 Wang M, Wang Y, Omari-siaw E, Wang S, Zhu Y, Xu X. Reduced Burst Release and Enhanced Oral Bioavailability in Shikimic Acid–Loaded Polylactic Acid Submicron Particles by Coaxial Electrospray. Journal of Pharmaceutical Sciences 2016;105:2427-36. [DOI: 10.1016/j.xphs.2016.05.032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
61 Tan JSL, Roberts C, Billa N. Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats. Journal of Biomaterials Science, Polymer Edition 2020;31:141-54. [DOI: 10.1080/09205063.2019.1680926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Aditya NP, Ko S. Solid lipid nanoparticles (SLNs): delivery vehicles for food bioactives. RSC Adv 2015;5:30902-11. [DOI: 10.1039/c4ra17127f] [Cited by in Crossref: 55] [Article Influence: 7.9] [Reference Citation Analysis]
63 Tian Q, Ding F, Guo L, Wang J, Wu F, Yu Y. Targeted solid lipid nanoparticles with peptide ligand for oral delivery of atorvastatin calcium. RSC Adv 2016;6:35901-9. [DOI: 10.1039/c6ra02371a] [Cited by in Crossref: 10] [Article Influence: 1.7] [Reference Citation Analysis]
64 Gadag S, Narayan R, Nayak AS, Catalina Ardila D, Sant S, Nayak Y, Garg S, Nayak UY. Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy. Int J Pharm 2021;606:120877. [PMID: 34252522 DOI: 10.1016/j.ijpharm.2021.120877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Guimarães KL, Ré MI. Lipid Nanoparticles as Carriers for Cosmetic Ingredients: The First (SLN) and the Second Generation (NLC). In: Beck R, Guterres S, Pohlmann A, editors. Nanocosmetics and Nanomedicines. Berlin: Springer Berlin Heidelberg; 2011. pp. 101-22. [DOI: 10.1007/978-3-642-19792-5_5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
66 Zhang X, Qiao H, Zhang T, Shi Y, Ni J. Enhancement of gastrointestinal absorption of isoliquiritigenin by nanostructured lipid carrier. Advanced Powder Technology 2014;25:1060-8. [DOI: 10.1016/j.apt.2014.02.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
67 Qi J, Zhuang J, Lu Y, Dong X, Zhao W, Wu W. In vivo fate of lipid-based nanoparticles. Drug Discov Today 2017;22:166-72. [PMID: 27713035 DOI: 10.1016/j.drudis.2016.09.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
68 Chen SQ, Song YQ, Wang C, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydr Polym 2020;230:115613. [PMID: 31887935 DOI: 10.1016/j.carbpol.2019.115613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
69 Grandhi BK, Thakkar A, Wang J, Prabhu S. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res (Phila) 2013;6:1015-25. [PMID: 24072676 DOI: 10.1158/1940-6207.CAPR-13-0172] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
70 Mahmoudian M, Valizadeh H, Zakeri-milani P. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation. Drug Development and Industrial Pharmacy 2018;44:1598-605. [DOI: 10.1080/03639045.2018.1483385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
71 McClements DJ. Edible lipid nanoparticles: digestion, absorption, and potential toxicity. Prog Lipid Res. 2013;52:409-423. [PMID: 23664907 DOI: 10.1016/j.plipres.2013.04.008] [Cited by in Crossref: 124] [Cited by in F6Publishing: 90] [Article Influence: 13.8] [Reference Citation Analysis]
72 Tan CS, Billa N, Roberts CJ, Scurr DJ. Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee'S Wax. Nanomaterials (Basel) 2014;4:905-16. [PMID: 28344257 DOI: 10.3390/nano4040905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
73 Rawal SU, Patel MM. Lipid nanoparticulate systems. Lipid Nanocarriers for Drug Targeting. Elsevier; 2018. pp. 49-138. [DOI: 10.1016/b978-0-12-813687-4.00002-5] [Cited by in Crossref: 12] [Article Influence: 3.0] [Reference Citation Analysis]
74 Chai G, Meng Y, Chen S, Hu F, Gan Y, Yuan H. Transport features and structural optimization of solid lipid nanoparticles crossing the intestinal epithelium. RSC Adv 2016;6:70433-45. [DOI: 10.1039/c6ra12978a] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Chaturvedi S, Verma A, Saharan VA. Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement. Adv Pharm Bull 2020;10:524-41. [PMID: 33072532 DOI: 10.34172/apb.2020.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P, Siva Kumar N, Vekariya RL. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv 2020;10:26777-91. [DOI: 10.1039/d0ra03491f] [Cited by in Crossref: 37] [Cited by in F6Publishing: 1] [Article Influence: 18.5] [Reference Citation Analysis]
77 Dong Z, Xie S, Zhu L, Wang Y, Wang X, Zhou W. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery. Drug Deliv 2011;18:441-50. [PMID: 21554156 DOI: 10.3109/10717544.2011.577109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
78 Joseph S, Bunjes H. Solid Lipid Nanoparticles for Drug Delivery. In: Douroumis D, Fahr A, editors. Drug Delivery Strategies for Poorly Water-Soluble Drugs. Oxford: John Wiley & Sons Ltd; 2013. pp. 103-49. [DOI: 10.1002/9781118444726.ch4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Xia F, Fan W, Jiang S, Ma Y, Lu Y, Qi J, Ahmad E, Dong X, Zhao W, Wu W. Size-Dependent Translocation of Nanoemulsions via Oral Delivery. ACS Appl Mater Interfaces 2017;9:21660-72. [PMID: 28616962 DOI: 10.1021/acsami.7b04916] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
80 Peng J, Jiang Z, Wu G, Cai Z, Du Q, Tao L, Zhang Y, Chen Y, Shen X. Improving protection effects of eucalyptol via carboxymethyl chitosan-coated lipid nanoparticles on hyperglycaemia-induced vascular endothelial injury in rats. J Drug Target 2021;29:520-30. [PMID: 33263461 DOI: 10.1080/1061186X.2020.1859514] [Reference Citation Analysis]
81 Wang G, Wang JJ, Chen XL, Du L, Li F. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. J Control Release 2016;235:276-90. [PMID: 27242199 DOI: 10.1016/j.jconrel.2016.05.045] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
82 Varshosaz J, Minayian M, Moazen E. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. Journal of Liposome Research 2010;20:115-23. [DOI: 10.3109/08982100903161456] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
83 Lefebvre DE, Venema K, Gombau L, Valerio LG Jr, Raju J, Bondy GS, Bouwmeester H, Singh RP, Clippinger AJ, Collnot EM, Mehta R, Stone V. Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices. Nanotoxicology 2015;9:523-42. [PMID: 25119418 DOI: 10.3109/17435390.2014.948091] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
84 Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opinion on Drug Delivery 2011;8:1407-24. [DOI: 10.1517/17425247.2011.604311] [Cited by in Crossref: 169] [Cited by in F6Publishing: 147] [Article Influence: 15.4] [Reference Citation Analysis]
85 Ali Khan A, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 2013;8:2733-44. [PMID: 23926431 DOI: 10.2147/IJN.S41521] [Cited by in Crossref: 31] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
86 Singh A, Yadagiri G, Parvez S, Singh OP, Verma A, Sundar S, Mudavath SL. Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. Mater Sci Eng C Mater Biol Appl 2020;117:111279. [PMID: 32919641 DOI: 10.1016/j.msec.2020.111279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
87 Chen S, Wang C, Tao S, Wang Y, Hu F, Yuan H. Rational Design of Redox-Responsive and P-gp-Inhibitory Lipid Nanoparticles with High Entrapment of Paclitaxel for Tumor Therapy. Adv Healthcare Mater 2018;7:1800485. [DOI: 10.1002/adhm.201800485] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
88 Chai GH, Xu Y, Chen SQ, Cheng B, Hu FQ, You J, Du YZ, Yuan H. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology. ACS Appl Mater Interfaces 2016;8:5929-40. [PMID: 26860241 DOI: 10.1021/acsami.6b00821] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
89 Yuan H, Wang L, Du Y, You J, Hu F, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids and Surfaces B: Biointerfaces 2007;60:174-9. [DOI: 10.1016/j.colsurfb.2007.06.011] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 7.3] [Reference Citation Analysis]
90 Hu X, Zhang J, Yu Z, Xie Y, He H, Qi J, Dong X, Lu Y, Zhao W, Wu W. Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine: Nanotechnology, Biology and Medicine 2015;11:1939-48. [DOI: 10.1016/j.nano.2015.06.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 9.1] [Reference Citation Analysis]
91 Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G. Oral bioavailability of curcumin: problems and advancements. Journal of Drug Targeting 2016;24:694-702. [DOI: 10.3109/1061186x.2016.1157883] [Cited by in Crossref: 198] [Cited by in F6Publishing: 80] [Article Influence: 33.0] [Reference Citation Analysis]
92 Huang J, Lu Y, Wang H, Liu J, Liao M, Hong L, Tao R, Ahmed MM, Liu P, Liu S, Fukunaga K, Du Y, Han F. The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain. Biomaterials 2013;34:7960-70. [DOI: 10.1016/j.biomaterials.2013.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
93 Alp G, Aydogan N. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer. Eur J Pharm Biopharm 2020;149:45-57. [PMID: 32014491 DOI: 10.1016/j.ejpb.2020.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Thakkar A, Chenreddy S, Wang J, Prabhu S. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles. Cell Biosci 2015;5:46. [PMID: 26301084 DOI: 10.1186/s13578-015-0041-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
95 Roger E, Lagarce F, Garcion E, Benoit JP. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) 2010;5:287-306. [PMID: 20148639 DOI: 10.2217/nnm.09.110] [Cited by in Crossref: 206] [Cited by in F6Publishing: 184] [Article Influence: 17.2] [Reference Citation Analysis]
96 Card JW, Jonaitis TS, Tafazoli S, Magnuson BA. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Critical Reviews in Toxicology 2011;41:20-49. [DOI: 10.3109/10408444.2010.524636] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
97 Varshosaz J, Moazen E. Novel lectin-modified poly(ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design. Pharmaceutical Development and Technology 2013;19:605-17. [DOI: 10.3109/10837450.2013.819011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
98 He SN, Li YL, Yan JJ, Zhang W, Du YZ, Yu HY, Hu FQ, Yuan H. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery. Int J Nanomedicine 2013;8:2859-69. [PMID: 23990715 DOI: 10.2147/IJN.S47967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
99 Rahman MA, Harwansh RK, Iqbal Z. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats. PNT 2019;7:162-76. [DOI: 10.2174/2211738507666190327145628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Sun M, Zhao L, Guo C, Cao F, Chen H, Zhao L, Tan Q, Zhu X, Zhu F, Ding T, Zhai Y, Zhai G. Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles. J Nanopart Res 2012;14. [DOI: 10.1007/s11051-011-0705-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
101 Singh I, Swami R, Pooja D, Jeengar MK, Khan W, Sistla R. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. Journal of Drug Targeting 2016;24:212-23. [DOI: 10.3109/1061186x.2015.1068320] [Cited by in Crossref: 60] [Cited by in F6Publishing: 13] [Article Influence: 8.6] [Reference Citation Analysis]
102 Chai G, Hu F, Sun J, Du Y, You J, Yuan H. Transport Pathways of Solid Lipid Nanoparticles Across Madin–Darby Canine Kidney Epithelial Cell Monolayer. Mol Pharmaceutics 2014;11:3716-26. [DOI: 10.1021/mp5004674] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
103 Zhang XG, Miao J, Li MW, Jiang SP, Hu FQ, Du YZ. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy. J Zhejiang Univ Sci B. 2008;9:506-510. [PMID: 18543406 DOI: 10.1631/jzus.b0820047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
104 Kumar S, Randhawa JK. Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone. RSC Adv 2015;5:68743-50. [DOI: 10.1039/c5ra10642g] [Cited by in Crossref: 41] [Article Influence: 5.9] [Reference Citation Analysis]
105 Hu X, Fan W, Yu Z, Lu Y, Qi J, Zhang J, Dong X, Zhao W, Wu W. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale 2016;8:7024-35. [PMID: 26725649 DOI: 10.1039/c5nr07474f] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 11.3] [Reference Citation Analysis]
106 Mehanna MM, Mneimneh AT. Formulation and Applications of Lipid-Based Nanovehicles: Spotlight on Self-emulsifying Systems. Adv Pharm Bull 2021;11:56-67. [PMID: 33747852 DOI: 10.34172/apb.2021.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Corzo C, Meindl C, Lochmann D, Reyer S, Salar-behzadi S. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2020;152:44-55. [DOI: 10.1016/j.ejpb.2020.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Lu W, Nishinari K, Phillips GO, Fang Y. Colloidal nutrition science to understand food-body interaction. Trends in Food Science & Technology 2021;109:352-64. [DOI: 10.1016/j.tifs.2021.01.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Kumar S, Randhawa JK. High melting lipid based approach for drug delivery: Solid lipid nanoparticles. Materials Science and Engineering: C 2013;33:1842-52. [DOI: 10.1016/j.msec.2013.01.037] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
110 Liang T, Yao Z, Ding J, Min Q, Jiang L, Zhu J. Cascaded Aptamers-Governed Multistage Drug-Delivery System Based on Biodegradable Envelope-Type Nanovehicle for Targeted Therapy of HER2-Overexpressing Breast Cancer. ACS Appl Mater Interfaces 2018;10:34050-9. [DOI: 10.1021/acsami.8b14009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
111 Gordillo-galeano A, Mora-huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics 2018;133:285-308. [DOI: 10.1016/j.ejpb.2018.10.017] [Cited by in Crossref: 131] [Cited by in F6Publishing: 103] [Article Influence: 32.8] [Reference Citation Analysis]